Oxygen and Fluid Pressure Measurements for Cervical Cancer

Recruiting in Palo Alto (17 mi)

Overseen byAnthony Fyles, MD

Age: 18+

Sex: Female

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Phase 2

Waitlist Available

Sponsor: University Health Network, Toronto

No Placebo Group

Prior Safety Data

Trial Summary

What is the purpose of this trial?The aim of this study is to measure the oxygen content and interstitial fluid pressure in cervix cancer patients. Tumour oxygen content and internal pressure of tumours may be an important factor that influences the effectiveness of radiotherapy and other treatments.

Eligibility Criteria

This trial is for individuals newly diagnosed with cervical cancer, specifically those with tumors 3 cm or larger. Participants must be undergoing an examination under anesthesia for staging and must provide informed consent to partake in the study.

Inclusion Criteria

Newly diagnosed patients with carcinoma of the cervix ( 3 cm in size or larger) where an examination under anesthesia is to be performed for staging purposes

Informed consent

Participant Groups

The study aims to measure oxygen levels and interstitial fluid pressure inside cervical cancer tumors. These measurements are taken before any treatment starts, as they may affect how well radiotherapy and other treatments work.

1Treatment groups

Experimental Treatment

Group I: Pre-treatment tumour oxygen measurements (under anesthesia)Experimental Treatment1 Intervention